Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Current Leases (2020 - 2025)

Historic Current Leases for Palisade Bio (PALI) over the last 6 years, with Q2 2025 value amounting to $24000.0.

  • Palisade Bio's Current Leases fell 8153.85% to $24000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $24000.0, marking a year-over-year decrease of 8153.85%. This contributed to the annual value of $90000.0 for FY2024, which is 2561.98% down from last year.
  • Per Palisade Bio's latest filing, its Current Leases stood at $24000.0 for Q2 2025, which was down 8153.85% from $58000.0 recorded in Q1 2025.
  • In the past 5 years, Palisade Bio's Current Leases registered a high of $184000.0 during Q2 2021, and its lowest value of $24000.0 during Q2 2025.
  • For the 5-year period, Palisade Bio's Current Leases averaged around $107500.0, with its median value being $111000.0 (2023).
  • As far as peak fluctuations go, Palisade Bio's Current Leases soared by 6769.23% in 2023, and later plummeted by 8153.85% in 2025.
  • Quarter analysis of 5 years shows Palisade Bio's Current Leases stood at $158000.0 in 2021, then tumbled by 33.54% to $105000.0 in 2022, then grew by 15.24% to $121000.0 in 2023, then dropped by 25.62% to $90000.0 in 2024, then crashed by 73.33% to $24000.0 in 2025.
  • Its Current Leases was $24000.0 in Q2 2025, compared to $58000.0 in Q1 2025 and $90000.0 in Q4 2024.